From: Exhaled nitric oxide and clinical phenotypes of childhood asthma
28 variables | factors | ||||||||
---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |
Clinical | |||||||||
gender | - 0.765 | ||||||||
age | - 0.879 | ||||||||
height | - 0.889 | ||||||||
weight | - 0.905 | ||||||||
BMI | - 0.751 | ||||||||
early wheezing (< 2 years) | - 0.339 | 0.565 | - 0.368 | ||||||
atopy (positive SPT) | 0.800 | ||||||||
parental smoking | 0.764 | ||||||||
Treatment | |||||||||
LABA | 0.840 | ||||||||
ICS treatment | 0.872 | ||||||||
ICS dose | 0.898 | ||||||||
ICS dose > 200 μg/d | 0.814 | ||||||||
Clinical events | |||||||||
partially or uncontrolled | 0.439 | 0.626 | |||||||
days with symptoms | 0.089 | 0.777 | |||||||
exacerbation | 0.942 | 0.054 | |||||||
days with oral steroid | 0.940 | 0.085 | |||||||
Baseline PFT values | |||||||||
FEV1 | 0.843 | ||||||||
FEV1/FVC | 0.843 | ||||||||
sRaw | - 0.609 | ||||||||
RV/TLC | 0.645 | 0.454 | |||||||
FEF50%/TLC | 0.834 | - 0.050 | |||||||
Post bronchodilator PFT values | |||||||||
FEV1 | 0.885 | ||||||||
FEV1/FVC | 0.757 | ||||||||
sRaw | - 0.391 | ||||||||
RV/TLC | 0.664 | ||||||||
FEF50%/TLC | 0.797 | 0.286 | |||||||
FEV1 response to BD % | - 0.569 | 0.397 | 0.392 | ||||||
Exhaled NO | - 0.061 | - 0.132 | - 0.119 | - 0.059 | 0.789 | - 0.149 | 0.064 | 0.030 | 0.076 |